Metagenomic Sequencing Market Size to Reach USD 1.97 Billion by 2032 | Key Trends & Insights
Global metagenomic sequencing market is undergoing rapid expansion as microbiome science, infectious disease surveillance, and precision medicine integrate deeper into clinical and research pipelines. Valued at USD 999 million in 2024, the market is expected to rise to USD 1.10 billion in 2025, ultimately reaching USD 1.97 billion by 2032, advancing at a CAGR of 10.4%. This strong trajectory reflects rising demand for comprehensive microbial analysis, improved sequencing affordability, and rapid adoption across environmental, clinical, and pharmaceutical applications.
Explore deeper insights at the 24LifeSciences Metagenomic Sequencing Market Report: https://www.24lifesciences.com/metagenomic-sequencing-market-9531
Global metagenomic sequencing market is undergoing rapid expansion as microbiome science, infectious disease surveillance, and precision medicine integrate deeper into clinical and research pipelines. Valued at USD 999 million in 2024, the market is expected to rise to USD 1.10 billion in 2025, ultimately reaching USD 1.97 billion by 2032, advancing at a CAGR of 10.4%. This strong trajectory reflects rising demand for comprehensive microbial analysis, improved sequencing affordability, and rapid adoption across environmental, clinical, and pharmaceutical applications.
Explore deeper insights at the 24LifeSciences Metagenomic Sequencing Market Report: https://www.24lifesciences.com/metagenomic-sequencing-market-9531
Metagenomic Sequencing Market Size to Reach USD 1.97 Billion by 2032 | Key Trends & Insights Global metagenomic sequencing market is undergoing rapid expansion as microbiome science, infectious disease surveillance, and precision medicine integrate deeper into clinical and research pipelines. Valued at USD 999 million in 2024, the market is expected to rise to USD 1.10 billion in 2025, ultimately reaching USD 1.97 billion by 2032, advancing at a CAGR of 10.4%. This strong trajectory reflects rising demand for comprehensive microbial analysis, improved sequencing affordability, and rapid adoption across environmental, clinical, and pharmaceutical applications. Explore deeper insights at the 24LifeSciences Metagenomic Sequencing Market Report: https://www.24lifesciences.com/metagenomic-sequencing-market-9531
0 Comments 0 Shares